Title | Type | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | %Female (1999) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Cancer Chemotherapy and Pharmacology | journal | 0.636 Q2 | 122 | 163 | 470 | 4403 | 841 | 466 | 1.78 | 27.01 | 28.93 | |
52 | Journal of Cancer Research and Clinical Oncology | journal | 0.617 Q2 | 109 | 106 | 352 | 3441 | 529 | 331 | 1.17 | 32.46 | 22.56 | |
53 | International Journal of Oncology | journal | 0.605 Q2 | 139 | 314 | 1063 | 4689 | 1300 | 1063 | 1.34 | 14.93 | 25.53 | |
54 | Cancer Letters | journal | 0.595 Q2 | 216 | 372 | 1257 | 9972 | 1919 | 1255 | 1.46 | 26.81 | 26.21 | |
55 | Oncology | journal | 0.577 Q2 | 107 | 118 | 306 | 3637 | 481 | 300 | 1.49 | 30.82 | 17.10 | |
56 | Current Problems in Cancer | journal | 0.575 Q2 | 47 | 14 | 29 | 544 | 41 | 28 | 2.29 | 38.86 | 0.00 | |
57 | Angiogenesis | journal | 0.572 Q2 | 101 | 39 | 49 | 1873 | 65 | 49 | 1.33 | 48.03 | 27.06 | |
58 | Invasion and Metastasis | journal | 0.555 Q2 | 31 | 11 | 76 | 419 | 102 | 76 | 0.96 | 38.09 | 31.25 | |
59 | Anticancer Research | journal | 0.544 Q2 | 136 | 876 | 2136 | 26890 | 3252 | 2134 | 1.45 | 30.70 | 27.43 | |
60 | European Journal of Cancer Part B: Oral Oncology | journal | 0.540 Q2 | 37 | 0 | 122 | 0 | 217 | 122 | 1.76 | 0.00 | 0.00 | |
61 | Tumor Biology | journal | 0.525 Q2 | 101 | 52 | 163 | 1385 | 216 | 163 | 1.29 | 26.63 | 24.12 | |
62 | Journal of Oral Pathology and Medicine | journal | 0.512 Q2 | 95 | 87 | 277 | 2651 | 351 | 276 | 1.24 | 30.47 | 24.31 | |
63 | Leukemia Research | journal | 0.508 Q3 | 96 | 153 | 452 | 4353 | 526 | 401 | 1.04 | 28.45 | 28.03 | |
64 | Leukemia and Lymphoma | journal | 0.501 Q3 | 102 | 299 | 906 | 10467 | 1208 | 897 | 1.15 | 35.01 | 30.44 | |
65 | Anti-Cancer Drugs | journal | 0.496 Q3 | 102 | 127 | 418 | 3493 | 725 | 410 | 1.83 | 27.50 | 21.26 | |
66 | Molecular and Cellular Differentiation | journal | 0.483 Q3 | 5 | 0 | 16 | 0 | 10 | 16 | 0.00 | 0.00 | 0.00 | |
67 | European Journal of Cancer Prevention | journal | 0.428 Q3 | 88 | 94 | 344 | 3308 | 379 | 321 | 1.25 | 35.19 | 33.50 | |
68 | Cancer Epidemiology | journal | 0.427 Q3 | 86 | 66 | 195 | 2388 | 207 | 195 | 0.91 | 36.18 | 28.26 | |
69 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.418 Q3 | 90 | 135 | 413 | 3008 | 466 | 403 | 1.04 | 22.28 | 23.70 | |
70 | Medical Oncology | journal | 0.405 Q3 | 90 | 43 | 114 | 1641 | 94 | 111 | 0.73 | 38.16 | 32.16 | |
71 | Lung Cancer | journal | 0.378 Q3 | 148 | 86 | 255 | 2131 | 269 | 245 | 1.04 | 24.78 | 21.32 | |
72 | Hematological Oncology | journal | 0.369 Q3 | 54 | 12 | 62 | 715 | 52 | 62 | 0.76 | 59.58 | 17.65 | |
73 | Oncology | journal | 0.367 Q3 | 83 | 256 | 903 | 4344 | 712 | 824 | 0.75 | 16.97 | 21.79 | |
74 | Molecular Imaging and Biology | journal | 0.353 Q3 | 78 | 35 | 25 | 894 | 25 | 25 | 1.00 | 25.54 | 18.88 | |
75 | Journal of Experimental Therapeutics and Oncology | journal | 0.352 Q3 | 40 | 0 | 48 | 0 | 41 | 48 | 0.00 | 0.00 | 0.00 | |
76 | Human Cell | journal | 0.351 Q3 | 44 | 26 | 107 | 390 | 68 | 107 | 0.47 | 15.00 | 9.86 | |
77 | Oral Oncology | journal | 0.351 Q3 | 137 | 99 | 134 | 3176 | 150 | 126 | 1.10 | 32.08 | 23.31 | |
78 | Recent Results in Cancer Research | book series | 0.345 Q3 | 63 | 10 | 224 | 804 | 182 | 224 | 0.75 | 80.40 | 27.78 | |
79 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.338 Q3 | 56 | 45 | 66 | 1356 | 69 | 64 | 1.04 | 30.13 | 48.42 | |
80 | Acta Oncologica, Supplement | journal | 0.335 Q3 | 8 | 12 | 4 | 598 | 2 | 4 | 2.00 | 49.83 | 19.23 | |
81 | Experimental Hematology | journal | 0.335 Q3 | 129 | 203 | 2293 | 8446 | 1379 | 2267 | 0.61 | 41.61 | 34.27 | |
82 | Japanese Journal of Clinical Oncology | journal | 0.332 Q3 | 95 | 154 | 352 | 2173 | 262 | 317 | 0.66 | 14.11 | 9.46 | |
83 | Cancer Treatment and Research | journal | 0.331 Q3 | 65 | 44 | 290 | 3998 | 224 | 290 | 0.51 | 90.86 | 22.08 | |
84 | Endocrine-Related Cancer | journal | 0.326 Q3 | 146 | 63 | 110 | 3043 | 93 | 108 | 0.81 | 48.30 | 34.71 | |
85 | Breast | journal | 0.307 | 98 | 79 | 232 | 1413 | 129 | 222 | 0.53 | 17.89 | 28.76 | |
86 | In Vivo | journal | 0.296 | 72 | 90 | 258 | 3341 | 204 | 257 | 0.88 | 37.12 | 26.06 | |
87 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.280 Q3 | 68 | 58 | 159 | 1859 | 106 | 141 | 0.76 | 32.05 | 25.86 | |
88 | Oncology Reports | journal | 0.278 Q3 | 115 | 247 | 786 | 1987 | 431 | 785 | 0.61 | 8.04 | 22.88 | |
89 | Prostate Cancer and Prostatic Diseases | journal | 0.278 Q3 | 78 | 116 | 59 | 2029 | 20 | 49 | 0.34 | 17.49 | 14.74 | |
90 | Growth Factors and Cytokines in Health and Disease | book series | 0.275 Q3 | 6 | 0 | 49 | 0 | 14 | 47 | 0.23 | 0.00 | 0.00 | |
91 | International Journal of Biological Markers | journal | 0.264 Q3 | 47 | 48 | 108 | 1281 | 54 | 86 | 0.50 | 26.69 | 41.89 | |
92 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.252 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
93 | Tumori | journal | 0.252 Q3 | 59 | 146 | 460 | 3355 | 286 | 456 | 0.49 | 22.98 | 32.45 | |
94 | Neoplasma | journal | 0.246 Q3 | 57 | 112 | 208 | 2292 | 135 | 207 | 0.57 | 20.46 | 44.06 | |
95 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.236 Q3 | 50 | 142 | 45 | 8141 | 25 | 45 | 1.17 | 57.33 | 0.00 | |
96 | Journal of Brachytherapy International | journal | 0.229 Q4 | 12 | 22 | 70 | 383 | 30 | 70 | 0.43 | 17.41 | 18.60 | |
97 | Oncologist | journal | 0.229 Q4 | 189 | 67 | 180 | 2206 | 71 | 160 | 0.41 | 32.93 | 29.41 | |
98 | Endocurietherapy/Hyperthermia Oncology | journal | 0.207 Q4 | 5 | 0 | 30 | 0 | 7 | 29 | 0.00 | 0.00 | 0.00 | |
99 | Journal of Experimental and Clinical Cancer Research | journal | 0.193 Q4 | 120 | 91 | 231 | 2264 | 98 | 224 | 0.51 | 24.88 | 24.56 | |
100 | Pathology and Oncology Research | journal | 0.184 Q4 | 61 | 54 | 68 | 1621 | 23 | 68 | 0.47 | 30.02 | 39.39 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®